Clario delivers study setup in 10 weeks for a global chronic weight management study

Pharmaceutical company benefits from Clario’s rapid setup in a Phase III trial

Summary

  • The sponsor required accelerated setup in a global Phase III study.
  • Our rapid approach delivered study setup in 10 weeks from kick-off.
  • Timelines were hit, sites were ready quicker and enrollment was accelerated.

Situation

  • A pharmaceutical sponsor conducted a global Phase III chronic weight management study.
  • This study took place at more than 100 sites and at participants’ homes in North America, Europe and APAC.
  • The sponsor required accelerated setup to meet study timelines as well as an eDiary to record blood glucose levels and ePRO responses.

The challenge

Fast set-up times ensure sponsors can more easily meet IRB submission and first patient in (FPI) dates. However, a number of factors can put pressure on timelines, such as: 

  • Complicated study documentation requiring detailed review and sign-off.
  • Delayed involvement of study team members post kick-off rather than early during the proposal stage.
  • Bespoke builds of assessments.
  • Questionnaire licensing and device provisioning on a global scale.

Partnering with the right eCOA provider who has the tools, technology and expertise to get trials up and running quickly is key.

Visit our type 2 diabetes and obesity therapeutic areas page to learn more about how we can help solve your study challenges. 

Clario’s rapid setup

Simplified eCOA Charter

  • Clario has a new simplified 25-page Customer Charter.

Early involvement of study team

  • Clario Solution Design and Programming teams were involved upfront.

Standardized assessments

  • Pre-built, pre-validated assessments from Clario’s library were used.

Our solution

We were engaged to provide remote and at-site eCOA data collection for the study.

The solution involved:

  • Provisioned at-site tablets with quality of life and suicide ideation and behavior (C-SSRS) assessments.
  • Provisioned at-home handhelds with daily dosing diaries.
  • U.S. English versions of assessments for translation.
  • Assessment licensing and device provisioning for each country by our global in-house logistics team.

We leveraged prior experience with working with the sponsor. This included re-using and re-engineering documentation and a library of sponsor-specific assessments, as well as integrating previous software builds and reporting.

Success factors

We completed the study setup in 10 weeks from kick-off.

Our approach involved:

Integration Icon Reverse RGB

Simplified eCOA Charter

  • Simplified and shorter documentation with accessible and easy-to-understand language.
  • Reduction in specification document from 125 pages to 25 pages.
Team Icon Reverse RGB

Early involvement of study team

  • Pre-assigned involvement of operational resources during the proposal review stage including our Clario Solution Design and Programming teams.
  • Quick and early build-out of the study documentation ensured.
Clinical Trial Management System Icon Reverse RGB

Standardized assessments

  • Pre-built and pre-validated assessments from our standardized library (representing half of those used).
  • Minimal modifications to assessments prior to release, accelerating setup.

Impact

Timelines hit

  • Our accelerated approach ensured the sponsor’s 10-week setup timeline was met.

Accelerated enrollment

  • Our solution expedited the arrival of devices on site, which meant sites could get ready quicker.
  • As a result, participant enrollment could start earlier.

Accelerate your patient enrollment and hit your study timelines

Visit our type 2 diabetes and obesity therapeutic areas page to learn more about how we can help solve your study challenges.